Page 114 - Eshre Final Programme 2015

TUESDAY 16 JUNE 2015
15:15 - 16:30 Evora
Selected oral communications: Session 48: Genes in monogenetic disease and fertility
Chairman: J.E.J. Smitz (Belgium) Chairman: S. Nunes (Portugal)
15:15 O-177
15:30 O-178
15:45 O-179
16:00 O-180
16:15 O-181
A novel preimplantation genetic diagnosis method for monogenic diseases by targeted sequencing
J. Li1, X.D. Zhang1, Y.W. Xu2, S.J. Liu1, Y.L. Huang1, G. Vajta3, H.F. Zhen1, X.T. Shen2, J. Wang2, Y.H. Zeng2, Y.T. Du3, C.Q. Zhou2
1BGI, Science&Technology, Shenzhen, China
2Sun Yat-sen University, The First Affiliated Hospital, Guangzhou, China 3BGI, healthcare, Shenzhen, China
Types of abnormal embryos in inversion cases
A. Suhotliv1, T. Escudero1, L. Ribustello1, P. Colls1, M. Konstantinidis2, S. Munne3
1Reprogenetics, aCGH Team, Livingston New Jersey, U.S.A. 2Reprogenetics, Research, Livingston New Jersey, U.S.A. 3Reprogenetics, CEO, Livingston New Jersey, U.S.A.
High cumulative success rate and excellent safety profile after trophectoderm biopsy, blastocyst vitrification and single thawed blastocyst transfer. A new era in PGD for inherited disorders
T. El-Toukhy1, M. Khalil1, M. Adel1, P. Renwick1, C. Mackie Ogilvie2, Y. Khalaf1
1Guy's Hospital Great Maze Pond, Assisted Conception Unit 11th floor, London, United Kingdom 2Guy's Hospital Great Maze Pond, Genetics, London, United Kingdom
Carrier screening: an analysis of observed carrier rates among a European population from an expanded panel
S. Yarnall1, N. Kumar1, S. Rodriguez1, S. Bristow1, A. Bisignano2, J. Horcajadas3
1Recombine, Product, New York N.Y., U.S.A. 2Recombine, CEO, New York N.Y., U.S.A. 3Recombine-EU, CSO, Sevilla, Spain
Mammalian Fertility Decoded: Over 3000 genetic loci implicated in female fertility potential.
D.E. Parfitt1, A. Conover1, T. Hu-Seliger1, B. Burnett1, S.T. Globus1, P. Yurttas Beim1
1Celmatix Inc, Research & Development, New York City NY, U.S.A.
114